| 000 -LEADER |
|---|
| fixed length control field |
06496nam a22002417a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230127151134.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230127b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128155851 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
AL |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
620.8 |
| Item number |
SHIB |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Craig Shimasaki |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
70034 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Biotechnology Entrepreneurship: Leading Managing and Commercializing Innovative Technologies |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
London |
| Name of publisher, distributor, etc. |
Academic Press |
| Date of publication, distribution, etc. |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxxiii,648 p. |
| Other physical details |
HB |
| Dimensions |
29x22 cm |
| 365 ## - TRADE PRICE |
|---|
| Price type code |
ABDI/0650/23 |
| Price amount |
₹7749.00 |
| Currency code |
$120.00 |
| Unit of pricing |
₹10332.00 |
| Price note |
25% |
| Price effective from |
16-01-2023 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Description<br/>This second edition of Biotechnology Entrepreneurship: Leading, Managing, and Commercializing Innovative Technologies is an authoritative, easy-to-read guide covering biotechnology entrepreneurship and the process of commercializing innovative biotechnology products. This best practice resource is for professional training programs, individuals starting a biotech venture, and for managers and experienced practitioners leading biotech enterprises. It is a valuable resource for those working at any level in the biotech industry, and for professionals who support and provide essential resources and services to the biotech industry. This practical, “how-to” book is written by seasoned veterans experienced in each of the operational functions essential for starting, managing, and leading a successful biotech company.Biotechnology Entrepreneurship explains the biotech business components and underlying strategies, interspersed with practical lessons from successful biotech entrepreneurs, educators, and experienced practitioners. These veteran contributors share their insights on how to be successful in this challenging but exciting industry. Subjects range from technology licensing and translating an idea into a viable business, forming your legal company entity, securing angel and venture capital, navigating product development, FDA regulatory approval, and biomanufacturing.This book is a user-friendly guide to decision-making and overall strategy written as a hands-on management tool for leaders and managers of these dynamic biotechnology ventures. If you are contemplating starting a biotech company, are a manager at any level, a seasoned veteran, or service provider in the biotech industry, this book is a “must read.”<br/><br/>Key Features<br/>This second edition includes several new chapters on topics such as:<br/>What you need to know about valuation and term sheets<br/>Investor presentations and what you need in a biotech investor pitch deck<br/>Mentorship and why you need mentors<br/>Artificial intelligence applications in biotech and pharma<br/>Common biotech entrepreneur mistakes and how to avoid them<br/> |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Table of Contents<br/>SECTION 1: UNDERSTANDING BIOTECHNOLOGY ENTREPRENEURSHIP<br/>1. What is Biotechnology Entrepreneurship?<br/>2. A Biotechnology Entrepreneur’s Story - Advice to Entrepreneurs: 2 Tributes to Henri A. Termeer<br/>3. A Biotechnology Entrepreneur's Story: From Start-up to International Contract Development and Manufacturing Organization<br/>4. Characteristics of Successful Biotechnology Leaders<br/><br/>SECTION 2: OVERVIEW OF THE BIOTECHNOLOGY INDUSTRY<br/>5. Unleashing the Promise of Biotechnology to Help Heal, Fuel and Feed the World<br/>6. Five Essential Elements for Growing Biotechnology Clusters<br/><br/>SECTION 3: THE HUMAN CAPITAL COMPONENT<br/>7. Building, Managing and Motivating Great Teams<br/>8. Building Human Relationship Networks<br/>9. Mentorship: Why You Need a Team of Mentors to be Successful<br/><br/>SECTION 4: THE INNOVATIVE TECHNOLOGY COMPONENT<br/>10. Understanding Biotechnology Product Sectors<br/>11. Technology Opportunities: Evaluating the Idea<br/>12. Understanding Biotechnology Business Models and Managing Risk<br/>13. Directing Your Technology Toward a Market Problem: What You Need to Know Before Applying the Business Model Canvas<br/><br/>SECTION 5: THE EMERGING BIOTECHNOLOGY ENTERPRISE<br/>14. Company Formation, Ownership Structure and Securities Issues<br/>15. Licensing the Technology: Biotechnology Commercialization Strategies Using University & Federal Labs<br/>16. Intellectual Property Protection Strategies for Biotechnology Innovations<br/><br/>SECTION 6: THE FINANICAL CAPITAL COMPONENT<br/>17. Sources of Capital and Investor Motivations<br/>18. How Investors Really Make Decisions: What Entrepreneurs Need to Know When Raising Money<br/>19. Securing Angel Capital and Understanding How Angel Networks Operate<br/>20. Understanding and Securing Venture Capital: an Entrepreneur's Perspective<br/>21. Financial Ramifications of Funding a Biotechnology Venture: What you Need to Know about Valuation and Term Sheets<br/>22. Your Business Plan and Presentation: Articulating Your Journey to Commercialization<br/>23. Investor Presentations: What Do You Need in an Investor Pitch Deck<br/><br/>SECTION 7: BIOTECHNOLOGY PRODUCT DEVELOPMENT<br/>24. Therapeutic Drug Development and Human Clinical Trials<br/>25. Integrating Diagnostic Applications into the Drug Development Workflow: Applications for Companion Diagnostics<br/>26. The Development and Commercialization of Medical Devices<br/>27. Commercialization and Applications of Agricultural Biotechnology<br/>28. Artificial Intelligence: Emerging Applications in Biotechnology and Pharma<br/>29. Regulatory Implications and Market Approval Considerations for Artificial Intelligence Products<br/>30. Regulatory Approval and Compliances for Biotechnology Products<br/>31. The Biomanufacturing of Biotechnology Products<br/><br/>SECTION 8: BIOTECHNOLOGY MARKET DEVELOPMENT<br/>32. Biotechnology Products and Their Customers: Developing a Successful Market Strategy<br/>33. Biotechnology Product Coverage, Coding, and Reimbursement Strategies<br/>34. Getting the Word Out: Public Relations Strategies to Support Biotechnology Business Goals<br/><br/>SECTION 9: THE LATTER-STAGE BIOTECHNOLOGY COMPANY<br/>35. Company Growth Stages and the Value of Corporate Culture<br/>36. Biotechnology Business Development: The Art of a Deal<br/>37. Biotech-Pharma Collaboration – A Strategic Tool: Case Study of Centocor<br/>38. The Emergence and Transformation of China in Biotechnology: Partnering with China<br/>39. Ethical Considerations for Biotechnology Entrepreneurs (suggested change to "Leaders")<br/>40. Diverse Career Opportunities in the Biotechnology and Life Sciences Industry<br/>41. Common Biotech Entrepreneur Mistakes and How to Avoid them<br/>42. Summary |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biotechnology Industries |
| 9 (RLIN) |
69972 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biotechnology |
| 9 (RLIN) |
69973 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
SHIMASAKI (Craig) Ed |
| 9 (RLIN) |
69974 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Book |
